STAT

Trump is dangerous, mental health experts claim in a new book. Are they right?

A new book on the president's mental health warns that he shows signs of "dangerous mental impairment" but ignores alternative explanations for Trump's behavior.

When pundits and political opponents warn that President Trump “is not mentally equipped” for the office he holds, that he might have “a psychiatric condition unfolding,” or that he could simply be “crazy,” it has little more credibility than the small hands/small [other anatomy] pseudo-medical assertion that the nation was treated to during the Republican primaries last year.

Two dozen mental health experts believed they could do better, and the result is the highly anticipated book, “The Dangerous Case of Donald Trump: 27 Psychiatrists and Mental Health Experts Assess a President,” which officially goes on sale next week.

The title’s reference to “danger” is crucial, for it opens the door to analyses that might otherwise violate a longstanding diktat from the American Psychiatric Association. Although its  prohibits APA members from commenting on the mental characteristics and possible

You're reading a preview, sign up to read more.

More from STAT

STAT1 min read
STAT Plus: Pharmalittle: Sanofi Walks Back Covid-19 Vaccine Remarks; Trump To Name Vaccine Czar With Conflicts
Sanofi insisted it would make its Covid-19 vaccine available in all countries, hours after chief executive Paul Hudson said the U.S. will get first access.
STAT1 min readSociety
STAT Plus: Pharmalittle: Hydroxychloroquine Fails To Help Patients In A Study; What Will States Do With The Old Malaria Drug Now?
After doubts arose about whether hydroxychloroquine is safe and effective for treating Covid-19, states are donating supplies to patients who need them to treat other illnesses or seeking refunds.
STAT1 min read
STAT Plus: Pharmalittle: Administration Mishandled Initial Remdesivir Distribution; AstraZeneca Lung Cancer Drug Shows Big Benefit
The Trump administration mishandled the initial distribution of remedesivir, the experimental Gilead Sciences Covid-19 medicine, delaying treatment to some critically ill patients.